M3633
4-甲基伞形酮基β-D-葡萄糖苷
β-glucosidase substrate, fluorogenic, ≥99% (HPLC), powder
别名:
MUD
登录 查看组织和合同定价。
选择尺寸
变更视图
关于此项目
经验公式（希尔记法）:
C16H18O8
化学文摘社编号:
分子量:
338.31
NACRES:
NA.32
PubChem Substance ID:
UNSPSC Code:
12352204
EC Number:
242-736-7
MDL number:
Beilstein/REAXYS Number:
94672
产品名称
4-甲基伞形酮基β-D-葡萄糖苷, β-glucosidase substrate
Quality Level
assay
≥99% (HPLC)
form
powder
solubility
DMF: 50 mg/mL, clear, colorless to faintly yellow
fluorescence
λex 316 nm; λem 372 nm (pH 9.1), λex 360 nm; λem 449 nm (Reaction product)
storage temp.
−20°C
SMILES string
CC1=CC(=O)Oc2cc(O[C@@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3O)ccc12
InChI
1S/C16H18O8/c1-7-4-12(18)23-10-5-8(2-3-9(7)10)22-16-15(21)14(20)13(19)11(6-17)24-16/h2-5,11,13-17,19-21H,6H2,1H3/t11-,13-,14+,15-,16-/m1/s1
InChI key
YUDPTGPSBJVHCN-YMILTQATSA-N
Application
4-甲基伞形酮基β-D-葡萄糖苷可用来作为以下反应的底物：
- 原发性海马神经元富含溶菌酶部分葡糖神经酰胺酶β 酶活性分析
- 酵母发酵过程中β-葡萄糖苷酶分析
- 巨噬细胞细胞系(RAW)中的葡萄糖脑苷脂酶1（GBA1）-相关葡萄糖苷酶活性分析
Biochem/physiol Actions
4-甲基伞形酮基β-D-葡萄糖苷是一种合成糖苷酶底物。它可用作来自肠球菌的葡萄糖苷酶底物。
存储类别
11 - Combustible Solids
wgk
WGK 3
flash_point_f
Not applicable
flash_point_c
Not applicable
ppe
Eyeshields, Gloves, type N95 (US)
法规信息
涉药品监管产品
此项目有
商品
Probiotics exhibit an inhibitory effect on pathogens, help prevent chronic intestinal inflammatory diseases or atopic syndromes, and support the immune system.
Assessing microbial safety of drinking water improving approaches and methods: Improving approaches and methods, 253-253 (2003)
K Kawamura et al.
Bone marrow transplantation, 52(10), 1390-1398 (2017-07-18)
HLA 1-locus-mismatched unrelated donors (1MMUD) have been used in allogeneic hematopoietic stem cell transplantation (allo-HCT) for patients who lack an HLA-matched donor. We retrospectively analyzed 3313 patients with acute leukemia or myelodysplastic syndrome who underwent bone marrow transplantation from an
Florent Malard et al.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation, 21(6), 1059-1067 (2015-02-25)
This retrospective report compared the 4-year outcomes of allogeneic stem cell transplantation (allo-SCT) in 651 adult patients with acute myeloid leukemia receiving a reduced-intensity (RIC) or nonmyeloablative conditioning (NMA) regimen according to the type of unrelated donors. These were either
全球贸易项目编号
| 货号 | GTIN |
|---|---|
| M3633-500MG | 04061835557684 |
| M3633-5G | 04061835557691 |
| M3633-100MG | 04061834050445 |
| M3633-1G | 04061834050452 |
| M3633-250MG | 04061835557677 |